Propanc Biopharma Statistics
Total Valuation
PPCB has a market cap or net worth of $23.56 million. The enterprise value is $24.13 million.
Important Dates
The last earnings date was Tuesday, September 30, 2025.
Earnings Date | Sep 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PPCB has 12.81 million shares outstanding.
Current Share Class | 12.81M |
Shares Outstanding | 12.81M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +168.42% |
Owned by Insiders (%) | 64.87% |
Owned by Institutions (%) | 3.90% |
Float | 3.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.84 |
P/TBV Ratio | 1.61 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.12.
Current Ratio | 1.50 |
Quick Ratio | 0.00 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -101.60 |
Financial Efficiency
Return on equity (ROE) is -1,163.67% and return on invested capital (ROIC) is -559.26%.
Return on Equity (ROE) | -1,163.67% |
Return on Assets (ROA) | -363.36% |
Return on Invested Capital (ROIC) | -559.26% |
Return on Capital Employed (ROCE) | -407.57% |
Revenue Per Employee | n/a |
Profits Per Employee | -$29.46M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.83% in the last 52 weeks. The beta is 19,890.49, so PPCB's price volatility has been higher than the market average.
Beta (5Y) | 19,890.49 |
52-Week Price Change | -88.83% |
50-Day Moving Average | 4.14 |
200-Day Moving Average | 9.73 |
Relative Strength Index (RSI) | 41.30 |
Average Volume (20 Days) | 378,699 |
Short Selling Information
The latest short interest is 188,412, so 1.47% of the outstanding shares have been sold short.
Short Interest | 188,412 |
Short Previous Month | 812 |
Short % of Shares Out | 1.47% |
Short % of Float | 5.81% |
Short Ratio (days to cover) | 0.04 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -57.28M |
Pretax Income | -58.92M |
Net Income | -58.92M |
EBITDA | -57.28M |
EBIT | -57.28M |
Earnings Per Share (EPS) | -$14.85 |
Full Income Statement Balance Sheet
The company has $12,088 in cash and $1.73 million in debt, giving a net cash position of -$1.71 million or -$0.13 per share.
Cash & Cash Equivalents | 12,088 |
Total Debt | 1.73M |
Net Cash | -1.71M |
Net Cash Per Share | -$0.13 |
Equity (Book Value) | 13.91M |
Book Value Per Share | 0.60 |
Working Capital | 2.77M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -405,168 |
Capital Expenditures | n/a |
Free Cash Flow | -405,168 |
FCF Per Share | -$0.03 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PPCB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -262.91% |
FCF Yield | -1.81% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:59,880.24.
Last Split Date | Jan 29, 2025 |
Split Type | Reverse |
Split Ratio | 1:59,880.24 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |